Found: 45
Select item for more details and to access through your institution.
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma.
- Published in:
- Cancer Reports, 2022, v. 5, n. 7, p. 1, doi. 10.1002/cnr2.1524
- By:
- Publication type:
- Article
Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 4, p. 1374, doi. 10.1111/bjh.19586
- By:
- Publication type:
- Article
Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 2, p. 542, doi. 10.1111/bjh.19475
- By:
- Publication type:
- Article
Low mortality from COVID‐19 infection in patients with B‐cell lymphoma after bispecific CD20xCD3 therapy.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 1, p. 356, doi. 10.1111/bjh.19156
- By:
- Publication type:
- Article
Little value of surveillance magnetic resonance imaging for primary CNS lymphomas in first remission: results from a Danish Multicentre Study.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 4, p. 671, doi. 10.1111/bjh.13988
- By:
- Publication type:
- Article
Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-up.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 1, p. 65, doi. 10.1111/bjh.14379
- By:
- Publication type:
- Article
Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 5, p. 876, doi. 10.1111/bjh.14325
- By:
- Publication type:
- Article
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 2, p. 236, doi. 10.1111/bjh.13943
- By:
- Publication type:
- Article
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
- Published in:
- British Journal of Haematology, 2015, v. 169, n. 3, p. 435, doi. 10.1111/bjh.13316
- By:
- Publication type:
- Article
Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim <sup>18</sup>F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.
- Published in:
- Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 410, doi. 10.23736/S1824-4785.17.02993-4
- By:
- Publication type:
- Article
Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 13, doi. 10.1007/s00277-022-05054-9
- By:
- Publication type:
- Article
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 3, p. 243, doi. 10.1111/ejh.13899
- By:
- Publication type:
- Article
Reference values for the EORTC QLQ‐C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 5, p. 697, doi. 10.1111/ejh.13601
- By:
- Publication type:
- Article
Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 18, p. 6565, doi. 10.1002/cam4.3298
- By:
- Publication type:
- Article
Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 12, p. 4395, doi. 10.1002/cam4.2981
- By:
- Publication type:
- Article
PET/CT in the management of haematological malignancies.
- Published in:
- European Journal of Haematology, 2008, v. 80, n. 5, p. 369, doi. 10.1111/j.1600-0609.2008.01051.x
- By:
- Publication type:
- Article
Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 3, p. 206, doi. 10.1111/j.1600-0609.2006.00802.x
- By:
- Publication type:
- Article
Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials.
- Published in:
- Journal of Cancer Survivorship, 2024, v. 18, n. 3, p. 727, doi. 10.1007/s11764-022-01305-w
- By:
- Publication type:
- Article
Novel precision medicine approaches and treatment strategies in hematological malignancies.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 4, p. 413, doi. 10.1111/joim.13697
- By:
- Publication type:
- Article
Uptake of FDG in Lemierre's syndrome with normal leucocyte scintigraphy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 3, p. 489, doi. 10.1007/s00259-003-1126-0
- By:
- Publication type:
- Article
An Epidemiological Model to Estimate the Prevalence of Diffuse Large B-Cell Lymphoma in the United States.
- Published in:
- 2022
- By:
- Publication type:
- journal article
ABCL-360: Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S394, doi. 10.1016/S2152-2650(21)01893-0
- By:
- Publication type:
- Article
HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S371, doi. 10.1016/S2152-2650(21)01849-8
- By:
- Publication type:
- Article
Poster:ABCL-360 Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S243, doi. 10.1016/S2152-2650(21)01526-3
- By:
- Publication type:
- Article
Poster: HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S236, doi. 10.1016/S2152-2650(21)01485-3
- By:
- Publication type:
- Article
Oral Abstract: ABCL-360: Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01279-9
- By:
- Publication type:
- Article
Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma Patients.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 4, p. 589, doi. 10.2967/jnumed.117.193946
- By:
- Publication type:
- Article
International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 5, p. 683, doi. 10.2967/jnumed.112.110890
- By:
- Publication type:
- Article
PET/CT for Therapy Response Assessment in Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 5, p. 21S, doi. 10.2967/jnumed.108.057190
- By:
- Publication type:
- Article
Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results From a Phase 2 Study.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 44
- By:
- Publication type:
- Article
Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 5, p. 848, doi. 10.1002/hon.3209
- By:
- Publication type:
- Article
Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
- By:
- Publication type:
- Article
Different histopathological subtypes of Hodgkin lymphoma show significantly different levels of FDG uptake.
- Published in:
- Hematological Oncology, 2006, v. 24, n. 3, p. 146, doi. 10.1002/hon.782
- By:
- Publication type:
- Article
Reply to H.J adams et al: 'Is FDG-PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B-cell lymphoma?'.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 2, p. E2, doi. 10.1002/ajh.24239
- By:
- Publication type:
- Article
Utility of interim and end-of-treatment PET/CT in peripheral T-cell lymphomas: A review of 124 patients.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 975, doi. 10.1002/ajh.24128
- By:
- Publication type:
- Article
Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish- Canadian study of 443 patients with diffuse-large B-cell lymphoma.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 11, p. 1041, doi. 10.1002/ajh.24169
- By:
- Publication type:
- Article
Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.
- Published in:
- American Journal of Hematology, 2014, v. 89, n. 6, p. 575, doi. 10.1002/ajh.23688
- By:
- Publication type:
- Article
Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 7, p. 744, doi. 10.1080/0284186X.2023.2195561
- By:
- Publication type:
- Article
Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 4, p. 608, doi. 10.1080/0284186X.2017.1279750
- By:
- Publication type:
- Article
<sup>123</sup>I‐MIBG imaging for detection of anthracycline‐induced cardiomyopathy.
- Published in:
- Clinical Physiology & Functional Imaging, 2018, v. 38, n. 2, p. 176, doi. 10.1111/cpf.12419
- By:
- Publication type:
- Article
Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.
- Published in:
- Oncologist, 2015, v. 20, n. 8, p. 890, doi. 10.1634/theoncologist.2015-0036
- By:
- Publication type:
- Article
FDG-PET/CT based response-adapted treatment.
- Published in:
- Cancer Imaging, 2012, v. 12, n. 2, p. 324, doi. 10.1102/1470-7330.2012.9006
- By:
- Publication type:
- Article
FDG-PET/CT based response-adapted treatment.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Axillary lymph nodes on PET in Hodgkin lymphoma after COVID‐19 vaccination.
- Published in:
- 2021
- By:
- Publication type:
- Case Study